These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Sandwich-format electrochemiluminescence assay for PDGF-BB using quantum dots-dendrimer nanocomposites as probe.
    Author: Zhang JJ, Cao JT, Shi GF, Liu YM, Chen YH, Ren SW.
    Journal: Talanta; 2015 Aug 15; 141():158-63. PubMed ID: 25966396.
    Abstract:
    This work describes a novel electrochemiluminescence aptasensor for highly sensitive detection of platelet-derived growth factor BB (PDGF-BB) using aptamer functionalized CdS quantum dots-polyamidoamine as probe (CdS QDs-PAMAM-Apt). CdS QDs-PAMAM nanocomposites were synthesized by one-pot synthesis in methanol. The prepared nanocomposites were linked with the NH2-aptamer 2 (Apt2) of PDGF-BB to form the CdS QDs-PAMAM-Apt2 probe by glutaraldehyde as coupling reagent. For constructing the aptasensor, MWCNTs-chitosan composites and NH2-aptamer 1 (Apt1) with the same base sequence as Apt2 were immobilized on the electrode by the self-assembled method to recognize the target protein PDGF-BB. In the presence of PDGF-BB, the structure of sandwiched format was formed between the Apt1 and the CdS QDs-PAMAM-Apt2 probe, thereby resulting in a proportional increase of ECL emission. Thanks to the efficient and stable ECL emission of CdS QDs-PAMAM dendrimer and the advantage of MWCNTs for accelerating the electron transfer, the highly sensitive detection of PDGF-BB with a detection limit of 0.13pM was achieved. The linear range is from 0.5pM to 1nM. The present protocol was applied to the analysis of PDGF-BB in human serum samples. The recoveries of PDGF-BB in human serum samples are 87.2-113% and RSD values are less than 3.6%.
    [Abstract] [Full Text] [Related] [New Search]